About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Cardiovascular Diseases group is a translational research group within the Cardiology Department of Vall d’Hebron Hospital that performs laboratory, clinical and epidemiological research. In the CIBERCV network we are within the topic of descriptor 2 “Arterial disease, thrombosis and myocardial ischemia-reperfusion injury”. Our contributions in these topics address the following lines:
In the CIBERESP network, our group is interested in the study of effectiveness/cost-effectiveness of cardiovascular interventions, health outcome research and methods in clinical research. The group has 19 principal investigators, 32 active projects and clinical trial and has been done 142 publications in 2020.
PMID: 35055345 Journal: Journal of Personalized Medicine Year: 2022 Reference: J Pers Med. 2022 Jan 2;12(1). pii: jpm12010030. doi: 10.3390/jpm12010030. Impact factor: 4.945 Publication type: Paper in international publication Authors: Herance, Jose Raul, Simo, Rafael, Velasquez, Mayra Alejandra, Paun, Bruno, Garcia-Leon, Daniel, Aparicio, Carolina, Mares, Roso, Simo-Servat, Olga, Castell-Conesa, Joan, Hernandez, Cristina et al. DOI: 10.3390/jpm12010030
PMID: 35067470 Journal: REVISTA ESPANOLA DE CARDIOLOGIA Year: 2022 Reference: Rev Esp Cardiol (Engl Ed). 2022 Jan 20. pii: S1885-5857(21)00373-X. doi: 10.1016/j.rec.2021.12.001. Impact factor: 4.753 Publication type: Paper in national publication Authors: Ois, Angel, Benito, Begona, Garcia-Elias, Anna, Ble, Mireia, Yanez Bisbe, Laia, Giralt-Steinhauer, Eva, Rodriguez-Campello, Ana, Cladellas Capdevila, Merce, Marti-Almor, Julio, Roquer, Jaume et al. DOI: 10.1016/j.rec.2021.12.001
PMID: 35068655 Journal: REVISTA ESPANOLA DE CARDIOLOGIA Year: 2022 Reference: Rev Esp Cardiol. 2022 Jun;75(6):532-535. doi: 10.1016/j.recesp.2021.11.031. Epub 2022 Jan 17. Impact factor: 4.753 Publication type: Letter whit IF Authors: Gonzalez-Del-Hoyo, Maribel, Servato, Luz, Rodenas, Eduardo, Baneras, Jordi, Ferreira-Gonzalez, Ignacio, Rodriguez-Palomares, Jose et al. DOI: 10.1016/j.recesp.2021.11.031
PMID: 35039531 Journal: Nature Reviews Disease Primers Year: 2022 Reference: Nat Rev Dis Primers. 2022 Jan 17;8(1):3. doi: 10.1038/s41572-022-00338-w. Impact factor: 52.329 Publication type: Letter or abstract Authors: Pyeritz, Reed E, Milewicz, Dianna M, Braverman, Alan C, De Backer, Julie, Morris, Shaine A, Boileau, Catherine, Maumenee, Irene H, Jondeau, Guillaume, Evangelista, Arturo et al. DOI: 10.1038/s41572-022-00338-w
PMID: 33632636 Journal: REVISTA ESPANOLA DE CARDIOLOGIA Year: 2021 Reference: Rev Esp Cardiol. 2021 Aug;74(8):710-712. doi: 10.1016/j.rec.2021.01.010. Epub 2021 Feb 23. Impact factor: 4.753 Publication type: Letter whit IF Authors: Dolader, Paola, Betrian Blasco, Pedro, Balcells, Joan, Izquierdo-Blasco, Jaume, Gran, Ferran, Marti Aguasca, Gerard et al. DOI: 10.1016/j.rec.2021.01.010
PMID: 33622636 Journal: REVISTA ESPANOLA DE CARDIOLOGIA Year: 2021 Reference: Rev Esp Cardiol (Engl Ed). 2021 Jun;74(6):558-559. doi: 10.1016/j.rec.2020.12.011. Epub 2021 Feb 5. Impact factor: 4.753 Publication type: Letter or abstract Authors: Pons-Pellice, Laura, Camio-Visauta, Elena, Chocron-Da Prat, Ivette, Rodriguez-Palomares, Jose Fernando, Roses Noguer, Ferran, de Nadal, Miriam et al. DOI: 10.1016/j.rec.2020.12.011
PMID: 33621347 Journal: EUROPEAN JOURNAL OF CLINICAL INVESTIGATION Year: 2021 Reference: Eur J Clin Invest. 2021 Jul;51(7):e13526. doi: 10.1111/eci.13526. Epub 2021 Mar 7. Impact factor: 4.686 Publication type: Paper in international publication Authors: Sambola, Antonia, Javier Elola, Francisco, Buera, Irene, Fernandez, Cristina, Bernal, Jose Luis, Ariza, Albert, Brindis, Ralph, Bueno, Hector, Rodriguez-Padial, Luis, Marin, Francisco et al. DOI: 10.1111/eci.13526
PMID: 32096926 Journal: CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS Year: 2021 Reference: Catheter Cardiovasc Interv. 2021 Feb 15;97(3):376-383. doi: 10.1002/ccd.28815. Epub 2020 Feb 25. Impact factor: 2.692 Publication type: Paper in international publication Authors: Ivey-Miranda, Juan, Flores-Umanzor, Eduardo J, Cepas-Guillen, Pedro L, Vazquez, Sara, Fernandez-Valledor, Andrea, Jimenez-Britez, Gustavo, Regueiro, Ander, Freixa, Xavier, Farrero, Marta, Ferreira-Gonzalez, Ignacio et al. DOI: 10.1002/ccd.28815
PMID: 31916413 Journal: ESC Heart Failure Year: 2020 Reference: ESC Heart Fail. 2020 Feb;7(1):25-35. doi: 10.1002/ehf2.12567. Epub 2020 Jan 9. Impact factor: 3.902 Publication type: Paper in international publication Authors: de Frutos, Fernando, Mirabet, Sonia, Ortega-Paz, Luis, Buera, Irene, Darnes, Sara, Andres, Bernardo, Adelino, Raquel, Bascompte, Ramon, Perez-Rodon, Jordi, Aparicio, Xavier et al. DOI: 10.1002/ehf2.12567
PMID: 31424609 Journal: EUROPEAN JOURNAL OF NEUROLOGY Year: 2020 Reference: Eur J Neurol. 2020 Feb;27(2):244-250. doi: 10.1111/ene.14061. Epub 2019 Sep 18. Impact factor: 4.516 Publication type: Paper in international publication Authors: Cuadrado-Godia, Elisa, Benito, Begona, Ois, Angel, Valles, Ermengol, Rodriguez-Campello, Ana, Giralt-Steinhauer, Eva, Cabrera, Sandra, Alcalde, Oscar, Jimenez-Lopez, Jesus, Jimenez-Conde, Jordi et al. DOI: 10.1111/ene.14061
PMID: 31539031 Journal: European Heart Journal-Cardiovascular Imaging Year: 2020 Reference: Eur Heart J Cardiovasc Imaging. 2020 Jan 1;21(1):24-33. doi: 10.1093/ehjci/jez222. Impact factor: 4.841 Publication type: Paper in international publication Authors: Fernandez-Hidalgo, Nuria, Permanyer, Eduard, Cuellar-Calabria, Hug, Romero-Farina, Guillermo, Rios, Remedios, Almirante, Benito, Castell-Conesa, Joan, Escobar, Manuel, Ferreira-Gonzalez, Ignacio, Tornos, Pilar et al. DOI: 10.1093/ehjci/jez222
PMID: 31377144 Journal: REVISTA ESPANOLA DE CARDIOLOGIA Year: 2020 Reference: Rev Esp Cardiol (Engl Ed). 2020 Jan;73(1):89-90. doi: 10.1016/j.rec.2019.06.005. Epub 2019 Jul 31. Impact factor: 4.642 Publication type: Letter whit IF Authors: Guala, Andrea, Dux-Santoy, Lydia, Teixido-Tura, Gisela, Johnson, Kevin M, Evangelista, Arturo, Rodriguez-Palomares, Jose et al. DOI: 10.1016/j.recesp.2019.06.018
PMID: 30430894 Journal: Pulmonary Circulation Year: 2019 Reference: Pulm Circ. 2019 Jan-Mar;9(1):2045894018816972. doi: 10.1177/2045894018816972. Epub 2018 Nov 15. Impact factor: 2.075 Publication type: Paper in international publication Authors: Domingo, Enric, Grignola, Juan, Trujillo, Pedro, Aguilar, Rio, Roman, Antonio et al. DOI: 10.1177/2045894018816972
The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.
In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.
The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.
